Journal
/
Immunology and Infection
/
-Cefoperazone behandelde muismodel van klinisch relevante<em> Clostridium difficile</em> Strain R20291
JoVE Journal
Immunology and Infection
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Immunology and Infection
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Please note that all translations are automatically generated. Click here for the English version.

-Cefoperazone behandelde muismodel van klinisch relevante<em> Clostridium difficile</em> Strain R20291

Nederlands

Automatically Generated

12,056 Views

•

06:51 min

•

December 10, 2016

DOI:

10.3791/54850-v

DOI:
10.3791/54850-v

•

06:51 min
December 10, 2016

•

5 Views
, , ,
1Department of Population Health and Pathobiology,North Carolina State University College of Veterinary Medicine, 2Department of Pathology and Laboratory Medicine, Lineberger Comprehensive Cancer Center,University of North Carolina School of Medicine

Summary

Automatically generated

Dit protocol beschrijft de cefoperazon muismodel van Clostridium difficile infectie (CDI) met een klinisch relevante en genetisch handelbaar stam, R20291. Nadruk op klinische ziekte monitoring, C. difficile bacteriële opsomming, toxine cytotoxiciteit en histopathologische veranderingen in heel CDI in een muismodel worden beschreven in het protocol.

Explore More Videos

Clostridium DifficileMouse ModelCefoperazoneSpore InoculumGavageAnaerobicDilutionEnumerationToxin CytotoxicityHistopathology

Read Article

Cite this Article

Winston, J. A., Thanissery, R., Montgomery, S. A., Theriot, C. M. Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291. J. Vis. Exp. (118), e54850, doi:10.3791/54850 (2016).

Download .ris file

Copy

Share Video

.

Copy